# NVIDIA Developer Forum & Community Showcase Guide

This guide provides instructions and a ready-to-publish presentation template for showcasing **Agentic BioNeMo** on the **NVIDIA Developer Forums**, **NVIDIA Technical Blog**, and AI/Biotech developer communities.

---

## 1. Where and How to Post on NVIDIA Developer Forum

### Step 1: Access the NVIDIA Developer Forums
1. Navigate to the [NVIDIA Developer Forums](https://forums.developer.nvidia.com/).
2. Log in or create an account using your NVIDIA Developer credentials.

### Step 2: Select the Relevant Forum Category
Post in one of the following high-visibility categories:
- **Primary Category**: **Healthcare & Life Sciences** (`Clara / BioNeMo`)
- **Secondary / Cross-Category**: **AI & Data Science** -> **Deep Learning & Inference** or **Generative AI Projects**

### Step 3: Configure Tags
Add the following searchable tags to maximize reach:
`bionemo`, `nim`, `generative-ai`, `ai-agents`, `drug-discovery`, `diffdock`, `molmim`, `esm2`, `cheminformatics`, `rdkit`

### Step 4: Submission Checklist
- [x] Catchy, informative title with `[Project Showcase]`.
- [x] Clear explanation of NVIDIA NIM integration (MolMIM + DiffDock + ESM-2).
- [x] Benchmark data & Pareto optimization tables.
- [x] Visual assets (link to GitHub `assets/cockpit_preview.png` and `pareto_frontier.png`).
- [x] Open-source GitHub repository link: [https://github.com/Jorwalzzz/bionemo-agentic-scientist](https://github.com/Jorwalzzz/bionemo-agentic-scientist)
- [x] Reproducibility instructions (Docker / 1-click CLI).

---

## 2. Copy-Paste Forum Post Template

*Copy the markdown below directly into the forum post editor:*

```markdown
# [Project Showcase] Agentic BioNeMo: Autonomous Multi-Agent AI Scientist for Target-to-Lead Drug Discovery (NIM MolMIM + DiffDock)

Hi NVIDIA Developer Community! 👋

I'm excited to share **Agentic BioNeMo**, an open-source autonomous multi-agent AI system for computer-aided drug design powered by **NVIDIA BioNeMo NIM microservices** (MolMIM, DiffDock, ESM-2), RDKit, and multi-objective Pareto optimization.

🔗 **GitHub Repository**: [https://github.com/Jorwalzzz/bionemo-agentic-scientist](https://github.com/Jorwalzzz/bionemo-agentic-scientist)  
📓 **Tutorial Notebook**: `notebooks/quickstart_agentic_drug_discovery.ipynb`  
🐳 **Docker Support**: `docker-compose up` for instant local deployment  

---

### The Problem: Fragmented Early-Stage Drug Discovery

Traditional computational drug discovery workflows require manual handoffs between distinct disciplines:
1. Structural biologists identify binding pockets and clean crystal structures.
2. Computational chemists run de novo generative models.
3. Medicinal chemists screen for ADMET liabilities and PAINS toxicophores.
4. Biophysicists run molecular docking simulations.
5. Principal Investigators review trade-offs and manually iterate.

**Agentic BioNeMo** automates this entire closed-loop lifecycle using 5 collaborating AI personas with autonomous feedback steering.

---

### System Architecture: 5 Specialized Autonomous Agents

1. **Target Scout Agent (Structural Biologist)**: Resolves clinical targets (UniProt/PDB), downloads crystal structures, cleans heteroatoms, validates canonical 20 IUPAC amino acid sequences, and maps 3D catalytic binding pockets.
2. **Generative Chemist Agent (De Novo Chemist)**: Explores latent chemical space around target-specific seeds using **NVIDIA NIM MolMIM** with CMA-ES property steering.
3. **ADMET Critic Agent (Medicinal Chemist)**: Screens candidates with RDKit for Lipinski Rule of 5 compliance, Veber oral bioavailability, QED drug-likeness, Synthetic Accessibility (SAScore), and PAINS reactive alert substructures.
4. **Biophysics Docking Agent (Structural Modeler)**: Samples 3D binding poses and computes binding free energy ($\Delta G$ in kcal/mol) using **NVIDIA NIM DiffDock**.
5. **Principal Investigator (PI) Agent (Research Director)**: Evaluates multi-parameter trade-offs using non-dominated **Pareto Frontier Optimization**, detects chemical liabilities, and autonomously issues Round 2 steering directives to the Generative Chemist.

```
[Clinical Target Query: "KRAS G12D"]
                │
                ▼
      ┌──────────────────┐
      │  PI Agent (Lead) │◄────────┐ (Round 2 Autonomous Feedback)
      └─────────┬────────┘         │
                │                  │
                ▼                  │
      ┌──────────────────┐         │
      │ 1. Target Scout  │         │
      └─────────┬────────┘         │
                │ PDB & Pocket     │
                ▼                  │
      ┌──────────────────┐         │
      │ 2. Gen Chemist   │─────────┤ (NIM MolMIM)
      └─────────┬────────┘         │
                │ SMILES           │
                ▼                  │
      ┌──────────────────┐         │
      │ 3. ADMET Critic  │─────────┤ (RDKit / PAINS / QED)
      └─────────┬────────┘         │
                │ Screened Leads   │
                ▼                  │
      ┌──────────────────┐         │
      │ 4. Biophysics    │─────────┘ (NIM DiffDock)
      └─────────┬────────┘
                │ 3D Docked Poses (ΔG)
                ▼
      ┌──────────────────┐
      │ Pareto Selection │ ──► Executive Dossier + 3D Cockpit
      └──────────────────┘
```

---

### Supported Targets Out of the Box

The system comes pre-configured with gold-standard structural targets:
- **KRAS G12D** (PDB: `8AZV`): Oncogenic switch-II pocket driver in adenocarcinoma.
- **EGFR T790M** (PDB: `2ITZ`): Acquired gatekeeper resistance mutation in NSCLC.
- **BRAF V600E** (PDB: `4MNE`): Constitutively active monomeric kinase in melanoma.
- **SARS-CoV-2 Mpro** (PDB: `7BQY`): Viral main protease homodimer catalytic dyad (Cys145/His41).
- **HER2 / ERBB2** (PDB: `3PP0`): Kinase domain amplified in breast and gastric carcinomas.

---

### Benchmark & Validation Results (KRAS G12D Campaign)

In an autonomous campaign targeting the **KRAS G12D switch-II pocket** (`8AZV`):
- **Seed Scaffold**: MRTX1133 parent
- **Nominated Lead**: `NIM-LEAD-01-06`
- **Predicted Binding Affinity ($\Delta G$)**: **-9.05 kcal/mol**
- **QED Drug-likeness**: **0.54**
- **Synthetic Accessibility (SAScore)**: **4.88** (Highly synthesizable)
- **ADMET Status**: 100% Lipinski compliant, 0 PAINS toxicophore alerts
- **Key Residue Contacts**: Asp12, Gly60, Gln61, Tyr96

---

### Interactive 3D Web Cockpit & Visualizations

The repository includes both a **FastAPI Glassmorphism Web Cockpit** and a **Streamlit Dashboard** featuring:
- WebGL 3D molecular viewer (`py3Dmol`) for rotating and zooming docked conformations.
- Live agent reasoning audit trail detailing hypotheses and feedback directives.
- Real-time Pareto frontier scatter plot and candidate ledger.
- One-click export for 300 DPI publication charts and multi-molecule SDF files.

---

### Quick Start (Try It in 2 Minutes)

```bash
# 1. Clone repository
git clone https://github.com/Jorwalzzz/bionemo-agentic-scientist.git
cd bionemo-agentic-scientist

# 2. Install dependencies
pip install -r requirements.txt

# 3. Run autonomous discovery campaign
python run_agentic_scientist.py --target "KRAS G12D" --candidates 10

# 4. Launch interactive Web Cockpit
python serve_cockpit.py --host 0.0.0.0 --port 8000
```

### Docker Deployment
```bash
docker-compose up --build
```

---

### Feedback & Collaboration

I would love to hear feedback from the BioNeMo team and fellow researchers:
1. What additional NIM endpoints or generative architectures would you like to see integrated?
2. Are there specific oncological or rare disease targets you'd like added to the benchmark library?

Feel free to check out the repo, star it, and open issues or discussions!

GitHub: **https://github.com/Jorwalzzz/bionemo-agentic-scientist**
```

---

## 3. Alternative Submission Channels

### A. NVIDIA Technical Blog Pitch
NVIDIA frequently features impactful open-source projects using NIM/BioNeMo on the official **NVIDIA Developer Blog**:
- Review the [NVIDIA Blog Submission Guidelines](https://developer.nvidia.com/blog/).
- Prepare a 500-word summary highlighting the **speedup**, **novelty of agentic coordination**, and **NIM MolMIM + DiffDock integration**.

### B. NVIDIA Developer Discord
- Join the official NVIDIA Developer Discord.
- Share your repository in the `#showcase` or `#healthcare-life-sciences` channels.

### C. GTC / BioNeMo Community Calls
- Submit an abstract or lightning demo for the next NVIDIA GTC or BioNeMo user group sessions.
